NCT02810925

Brief Summary

The patients are randomized into 4 groups : Patients undergoing PENS of dermatome T6 in and a 1200 Kcal diet (Group 1), Patients undergoing PENS T6 and a 2000 Kcal/day, Patients undergoing transcutaneous electrical neurostimulation (TENS) of Dermatomes T11-T12 and following a 1200 Kcal diet and those patients following only a 1200 Kcal diet (Group 4). Weight loss, appetite and ghrelin levels at baseline and after treatment are investigated.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Jul 2015

Shorter than P25 for phase_3

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2015

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

June 21, 2016

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 23, 2016

Completed
Last Updated

June 23, 2016

Status Verified

June 1, 2016

Enrollment Period

5 months

First QC Date

June 21, 2016

Last Update Submit

June 21, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Weight loss

    Weight loss will be evaluated after 12 weeks of treatment

    After 12 weeks of treatment

Study Arms (4)

PENS T6 and 1200 Kcal/day diet

EXPERIMENTAL

Patients undergo 12 sessions of percutaneous electrical stimulation of dermatome T6 (PENS T6), weekly, during 12 weeks. During this period they follow a hypocaloric 1200 Kcal/day diet.

Procedure: PENS T6Dietary Supplement: Hypocaloric 1200 Kcal/day diet

PENST6 + Normocaloric 2000 Kcal/day diet

ACTIVE COMPARATOR

Patients undergo 12 sessions of percutaneous electrical stimulation of dermatome T6 (PENS T6), weekly, during 12 weeks. During this period they follow a normocaloric 2000 Kcal/day diet.

Procedure: PENS T6Dietary Supplement: Normocaloric 2000 Kcal/day diet

TENS T11/ T12 + 1200 Kcal/day diet

PLACEBO COMPARATOR

Patients undergo 12 sessions of transcutaneous electrical stimulation of dermatomes T11-T12 , weekly, during 12 weeks. During this period they follow a hypocaloric 1200 Kcal/day diet.

Procedure: TENS T11/T12Dietary Supplement: Hypocaloric 1200 Kcal/day diet

1200 Kcal/day diet

ACTIVE COMPARATOR

Patients follow only a hypocaloric 1200 Kcal/day diet.

Dietary Supplement: Hypocaloric 1200 Kcal/day diet

Interventions

PENS T6PROCEDURE

Patients undergo percutaneous electrical stimulation of dermatome T6, weekly, during 12 weeks.

PENS T6 and 1200 Kcal/day dietPENST6 + Normocaloric 2000 Kcal/day diet
TENS T11/T12PROCEDURE

Patients undergo transcutaneous electrical stimulation of dermatomes T11-T12, weekly, during 12 weeks.

TENS T11/ T12 + 1200 Kcal/day diet

Patients follow a Hypocaloric 1200 Kcal/day diet during 12 weeks.

1200 Kcal/day dietPENS T6 and 1200 Kcal/day dietTENS T11/ T12 + 1200 Kcal/day diet

Patients follow a Normocaloric 2000 Kcal/day diet during 12 weeks.

PENST6 + Normocaloric 2000 Kcal/day diet

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with obesity (BMI\>30 Kg/m2) or overweight (BMI 25-30 Kg/m2)

You may not qualify if:

  • Untreated endocrine disease causing obesity
  • Serious psychiatric illness.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Weight Loss

Interventions

Diet

Condition Hierarchy (Ancestors)

Body Weight ChangesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Nutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Dolores Castro

    Clinica Garcilaso

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Neurostimulation Unit. Garcilaso Clinic

Study Record Dates

First Submitted

June 21, 2016

First Posted

June 23, 2016

Study Start

July 1, 2015

Primary Completion

December 1, 2015

Study Completion

December 1, 2015

Last Updated

June 23, 2016

Record last verified: 2016-06

Data Sharing

IPD Sharing
Will share

Data might be published in a journal, always preserving patients´ confidentiality.